05. Dec 2017 | 2 min read

Oslo, 4 December 2017
Following today's purchase of 160.000 shares in Gentian Diagnostics, Vatne Equity AS owns 760.000 shares in the Company, corresponding to 5,43% of the outstanding shares. In addition, Lioness AS, a sister company of Vatne Equity AS, has today purchased 100.000 shares in Gentian Diagnostic ASA, corresponding to 0,71% of the outstanding shares. Vatne Equity AS and Lioness AS together own 860.000 shares in Gentian Diagnostics, corresponding to 6,14% of the outstanding shares.
For further information, please contact: Henrik Krefting, CEO (+47) 916 12 279 / Email: hk@vatnecapital.com
MeldingsID 440077

You may also read